Corporate News 15-Jun-19
FDC receives USFDA approval for Dorzolamide and Timolol Ophthalmic Solution
FDC has been granted ANDA approval by United States Food and Drug Administration (USFDA), for Dorzolamide and Timolol Ophthalmic Solution USP 22.3mg/6.83mg per ml, a generic version of Cosopt of Oak Pharmaceuticals Inc.
Previous News
FDC to announce Quarterly Result
( Corporate News - 18-May-24 12:29 )
FDC to conduct AGM
( Corporate News - 01-Sep-23 12:51 )
Board of FDC to consider proposal for buyback
( Corporate News - 03-Aug-23 11:29 )
Volumes spurt at SRF Ltd counter
( Hot Pursuit - 12-Jun-23 11:00 )
Volumes jump at FDC Ltd counter
( Hot Pursuit - 03-Jan-24 14:30 )
Volumes spurt at Go Fashion (India) Ltd counter
( Hot Pursuit - 12-Jun-23 14:30 )
Volumes spurt at FDC Ltd counter
( Hot Pursuit - 03-Jan-24 11:00 )
FDC consolidated net profit rises 1.48% in the December 2020 quarter
( Results - Announcements 05-Feb-21 17:42 )
FDC schedules board meeting
( Corporate News - 02-Aug-23 17:56 )
FDC Ltd Falls 1.55%
( Hot Pursuit - 09-May-23 09:45 )
FDC standalone net profit declines 31.35% in the December 2016 quarter
( Results - Announcements 03-Feb-17 18:04 )
Other Stories
Gujarat Toolroom to conduct EGM
08-Jul-24 19:53
Macro Intl. to conduct AGM
08-Jul-24 19:52
Ecoboard Industries schedules AGM
08-Jul-24 19:52
Eraaya Lifespaces schedules EGM
08-Jul-24 19:52
Binny to convene EGM
08-Jul-24 19:52
ICRA upgrades long term rating on bank facilities of Keystone Realtors
08-Jul-24 19:17
Sadbhav Engineering schedules EGM
08-Jul-24 19:08
Board of Va Tech Wabag approves divestment of Wabag Romania
08-Jul-24 19:08
Global Capital Markets to announce Quarterly Result
08-Jul-24 19:07
Motherson Sumi Wiring India schedules board meeting
08-Jul-24 19:07
Back
Top
